Ameriprise Financial Inc Puma Biotechnology, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.63 - $9.39 $1.2 Million - $1.7 Million	-180,938 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.98 - $11.6 $746,722 - $964,586	-83,154 Reduced 31.49%	180,938 $1.66 Million
Q1 2021 May 17, 2021	BUY	$9.38 - $13.63 $82,384 - $119,712	8,783 Added 3.44%	264,092 $2.56 Million
Q4 2020 Feb 12, 2021	SELL	$7.78 - $12.13 $34,550 - $53,869	-4,441 Reduced 1.71%	255,309 $2.62 Million
Q3 2020 Nov 16, 2020	BUY	$9.5 - $11.14 $456,522 - $535,332	48,055 Added 22.7%	259,750 $2.62 Million
Q2 2020 Aug 14, 2020	BUY	$7.01 - $13.24 $330,689 - $624,583	47,174 Added 28.67%	211,695 $2.21 Million
Q1 2020 May 15, 2020	BUY	$6.28 - $14.57 $134,410 - $311,841	21,403 Added 14.95%	164,521 $1.39 Million
Q4 2019 Feb 14, 2020	BUY	$6.5 - $10.73 $30,381 - $50,152	4,674 Added 3.38%	143,118 $1.25 Million
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $121,091 - $177,831	13,839 Added 11.11%	138,444 $1.49 Million
Q2 2019 Aug 14, 2019	SELL	$12.3 - $35.76 $1.76 Million - $5.1 Million	-142,688 Reduced 53.38%	124,605 $1.58 Million
Q1 2019 May 15, 2019	SELL	$20.77 - $42.37 $1.57 Million - $3.21 Million	-75,771 Reduced 22.09%	267,293 $10.4 Million
Q4 2018 Feb 14, 2019	BUY	$20.07 - $46.7 $351,204 - $817,203	17,499 Added 5.37%	343,064 $6.98 Million
Q3 2018 Nov 14, 2018	SELL	$41.2 - $59.85 $393,666 - $571,866	-9,555 Reduced 2.85%	325,565 $14.9 Million
Q2 2018 Aug 14, 2018	SELL	$48.3 - $68.25 $3.62 Million - $5.11 Million	-74,914 Reduced 18.27%	335,120 $19.8 Million
Q1 2018 May 15, 2018	BUY	$59.7 - $99.25 $4.89 Million - $8.14 Million	81,971 Added 24.99%	410,034 $27.9 Million
Q4 2017 Feb 12, 2018	BUY	$93.85 - $132.45 $15.3 Million - $21.5 Million	162,516 Added 98.17%	328,063 $32.4 Million
Q3 2017 Nov 07, 2017	BUY	$72.0 - $119.75 $11.9 Million - $19.8 Million	165,547	165,547 $19.8 Million

Others Institutions Holding PBYI

# of Institutions

102

Shares Held

29.1M

Call Options Held

60.6K

Put Options Held

16.3K

Vanguard Group Inc Valley Forge, PA

3.64M
Shares

$10.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$10.4 Million
0.0% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.06M
Shares

$8.88 Million
0.42% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.88M
Shares

$8.35 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.97M
Shares

$5.71 Million
0.02% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account